U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 18-24, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 18-24, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 02/22/2024
Location: College Park, MD
Subject: Food Safety Issues and FDA Human Foods Program Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Executive staff and members of the International Food Additives Council

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 02/21/2024
Location: Washington, DC
Subject: Reagan-Udall Foundation Public Workshop - Qualifying Biomarkers to Support Rare Disease Regulatory Pathways; Biomarkers in Rare Genetic Diseases
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and patient advocate stakeholders

Event Date: 02/21/2024
Location: Cambridge, MA
Subject: Biotech Forum; Fireside Chat on Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry stakeholders

Event Date: 02/23/2024
Location: Virtual
Subject: American Society of Gene and Cell Therapy / FDA Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representatives from the American Society of Gene & Cell Therapy

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 02/20/2024
Location: Washington, DC
Subject: Association for the Advancement of Medical Instrumentation Medical Device Standard Conference: Keynote Speaker
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders

Event Date: 02/22/2024
Location: Silver Spring, MD
Subject: Regulatory Science Updates
FDA Participant/Group: MICHELLE TARVER; RANDALL BROCKMAN; DANIEL CANOS; WILLIAM MAISEL; OWEN FARIS; MARTHA BETZ;
Non FDA Participant/Group: Aaron Goodstein, Chuck Medovich, Diane Johnson, Heather Colvin, Jijo James, Raina Dauria, Saadia Saad-Kaufman, Stephanie Koenig (Johnson and Johnson);

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 02/23/2024
Location: Virtual
Subject: Produce Safety Coalition Collaboration on Best Practices and Data Sharing/ Transparency to Enhance Produce Safety
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Hilary Thesmar (Food Marketing Institute); Barbara Kowalcyk (George Washington University); Brian Ronholm (Consumer Reports); Natalie Dyenson (International Fresh Produce Association (IFPA)); Jennifer McEntire (Food Safety Strategy); Joe Reardon (National Association of State Department of Agriculture (NASDA)); DeAnn Davis (Western Growers Association); Mitzi Baum; Mike Taylor (STOP Foodborne Illness);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 02/20/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives of Reynolds American Inc

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top